Subscribe To
Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
BRISBANE, Calif., May 10, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, today reported financial results for the quarter ended March 31, 2023 and provided a corporate update. “The first few months of 2023 set the pace for what we […] The post Tempest Reports First Quarter 2023 Financial Results and Provides Business Update appeared first on For...
Read More
Posted: May 10 2023, 20:15
Author Name: forextv
Views: 081757